IL44862A - A blood control standard and its preparation - Google Patents

A blood control standard and its preparation

Info

Publication number: IL44862A
Authority: IL; Israel
Prior art keywords: yeast; dextrose; blood; per; blood plasma
Prior art date: 1973-08-10

Application number

IL44862A

Other languages

English (en)

Other versions

IL44862A0 (en

Original Assignee

Baxter Travenol Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-08-10

Filing date

1974-05-20

Publication date

1977-01-31

1974-05-20 Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab

1974-07-31 Publication of IL44862A0 publication Critical patent/IL44862A0/xx

1977-01-31 Publication of IL44862A publication Critical patent/IL44862A/en

Links

210000004369 blood Anatomy 0.000 title claims description 23
239000008280 blood Substances 0.000 title claims description 23
238000002360 preparation method Methods 0.000 title description 5
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 38
235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 38
210000002381 plasma Anatomy 0.000 claims description 30
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 29
239000008121 dextrose Substances 0.000 claims description 24
238000000034 method Methods 0.000 claims description 11
230000012010 growth Effects 0.000 claims description 9
230000005526 G1 to G0 transition Effects 0.000 claims description 7
239000003146 anticoagulant agent Substances 0.000 claims description 7
229940127219 anticoagulant drug Drugs 0.000 claims description 7
238000010564 aerobic fermentation Methods 0.000 claims description 5
230000001133 acceleration Effects 0.000 claims description 4
239000007788 liquid Substances 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
239000000047 product Substances 0.000 description 8
210000002966 serum Anatomy 0.000 description 7
238000003556 assay Methods 0.000 description 6
239000000463 material Substances 0.000 description 6
210000004027 cell Anatomy 0.000 description 5
239000008103 glucose Substances 0.000 description 5
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
239000011347 resin Substances 0.000 description 4
229920005989 resin Polymers 0.000 description 4
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000006378 damage Effects 0.000 description 3
238000000855 fermentation Methods 0.000 description 3
230000004151 fermentation Effects 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
241000222120 Candida <Saccharomycetales> Species 0.000 description 2
241000235646 Cyberlindnera jadinii Species 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
108090000190 Thrombin Proteins 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000003698 anagen phase Effects 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
235000019441 ethanol Nutrition 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000011491 glass wool Substances 0.000 description 2
239000003456 ion exchange resin Substances 0.000 description 2
229920003303 ion-exchange polymer Polymers 0.000 description 2
244000005700 microbiome Species 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
239000013618 particulate matter Substances 0.000 description 2
229910001414 potassium ion Inorganic materials 0.000 description 2
239000002994 raw material Substances 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
229910001415 sodium ion Inorganic materials 0.000 description 2
229960004072 thrombin Drugs 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
101000929940 Homo sapiens Adrenocortical dysplasia protein homolog Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
244000253911 Saccharomyces fragilis Species 0.000 description 1
241001123227 Saccharomyces pastorianus Species 0.000 description 1
241000006364 Torula Species 0.000 description 1
230000002411 adverse Effects 0.000 description 1
GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
235000012538 ammonium bicarbonate Nutrition 0.000 description 1
239000001099 ammonium carbonate Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
229960004756 ethanol Drugs 0.000 description 1
238000000605 extraction Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012467 final product Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
-1 for example Substances 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
102000054726 human ACD Human genes 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
229910001410 inorganic ion Inorganic materials 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
239000000523 sample Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000010421 standard material Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000012607 strong cation exchange resin Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/802—Logarithmic growth phase
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
- Y10S435/942—Saccharomyces cerevisiae
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/104998—Glucose, ketone, nitrate standard or control
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Veterinary Medicine (AREA)
Food Science & Technology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Neurosurgery (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Developmental Biology & Embryology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)

IL44862A 1973-08-10 1974-05-20 A blood control standard and its preparation IL44862A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US387419A US3897363A (en)	1973-08-10	1973-08-10	Blood control standard

Publications (2)

Publication Number	Publication Date
IL44862A0 IL44862A0 (en)	1974-07-31
IL44862A true IL44862A (en)	1977-01-31

Family

ID=23529784

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL44862A IL44862A (en)	1973-08-10	1974-05-20	A blood control standard and its preparation

Country Status (10)

Country	Link
US (1)	US3897363A (fr)
JP (1)	JPS5040193A (fr)
BE (1)	BE815166A (fr)
CA (1)	CA1030448A (fr)
DE (1)	DE2430622A1 (fr)
DK (1)	DK425274A (fr)
FR (1)	FR2240452A1 (fr)
GB (1)	GB1440289A (fr)
IL (1)	IL44862A (fr)
IT (1)	IT1017819B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2461969A1 (de) *	1974-12-31	1976-07-08	Behringwerke Ag	Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
US6248869B1 (en)	1997-05-29	2001-06-19	Medical Analysis Systems, Inc.	Troponin I forms and use of the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1788628A (en) *	1925-12-22	1931-01-13	California Packing Corp	Process of treating sugar solutions
US2744017A (en) *	1950-08-15	1956-05-01	Ben L Sarett	Removal of sugars by enzymatic process
US2651592A (en) *	1950-08-15	1953-09-08	Ben L Sarett	Enzymatic process for producing gluconic acid
US3092465A (en) *	1960-03-25	1963-06-04	Miles Lab	Diagnostic test device for blood sugar
US3466249A (en) *	1967-02-13	1969-09-09	Baxter Laboratories Inc	Blood serum reference standard for multi-automated analytical procedures
US3629142A (en) *	1969-12-08	1971-12-21	Edward P Marbach	Reference standard blood serum for the calibration of automatic blood serum analyzing apparatus
US3682835A (en) *	1970-11-24	1972-08-08	Baxter Laboratories Inc	Liquid blood serum control standard
US3717549A (en) *	1971-02-09	1973-02-20	Pfizer	Fermentation process for the production of citric acid
US3751381A (en) *	1971-04-27	1973-08-07	Warner Lambert Co	Dyed albumen-cohn fraction iii-lipid mixtures serum lipid assay standard
US3753925A (en) *	1972-03-24	1973-08-21	Baxter Laboratories Inc	Cerebrospinal fluid control standard

1973
- 1973-08-10 US US387419A patent/US3897363A/en not_active Expired - Lifetime
1974
- 1974-05-03 CA CA198,888A patent/CA1030448A/fr not_active Expired
- 1974-05-17 BE BE144425A patent/BE815166A/fr unknown
- 1974-05-20 IL IL44862A patent/IL44862A/en unknown
- 1974-06-03 JP JP49062767A patent/JPS5040193A/ja active Pending
- 1974-06-05 GB GB2486974A patent/GB1440289A/en not_active Expired
- 1974-06-26 DE DE2430622A patent/DE2430622A1/de active Pending
- 1974-06-28 FR FR7422591A patent/FR2240452A1/fr not_active Withdrawn
- 1974-08-01 IT IT25865/74A patent/IT1017819B/it active
- 1974-08-09 DK DK425274A patent/DK425274A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
FR2240452A1 (fr)	1975-03-07
US3897363A (en)	1975-07-29
JPS5040193A (fr)	1975-04-12
BE815166A (fr)	1974-09-16
IL44862A0 (en)	1974-07-31
AU6995874A (en)	1975-12-11
IT1017819B (it)	1977-08-10
DK425274A (fr)	1975-04-21
GB1440289A (en)	1976-06-23
CA1030448A (fr)	1978-05-02
DE2430622A1 (de)	1975-02-27

Publication	Publication Date	Title
Kodicek	1940	Estimation of nicotinic acid in animal tissues, blood and certain foodstuffs: Applications
US3973913A (en)	1976-08-10	Blood control standard
Litwack	1955	Photometric determination of lysozyme activity.
US3466249A (en)	1969-09-09	Blood serum reference standard for multi-automated analytical procedures
EP0465510B1 (fr)	1995-01-25	Solution de reference stable d'hemoglobine
US3235337A (en)	1966-02-15	Diagnostic compositions and test indicators
Byers et al.	1969	Cell Size, Macromolecule Composition, Nuclear Number, Oxygen Consumption and Cyst Formation During Two Growth Phases in Unagitated Cultures of Acanthamoeba castellanii 1
EP0007345A1 (fr)	1980-02-06	Procede de preparation de compositions biologiques utilisees comme controles-temoins dans les analyses diagnostiques
Al-Ali et al.	1988	A comprehensive biochemical analysis of the blood of the camel (Camelus dromedarius)
US4199471A (en)	1980-04-22	Freeze-stable liquid blood control standard
US4126575A (en)	1978-11-21	Blood control standard
Meiklejohn	1937	The estimation of vitamin B1 in blood by a modification of Schopfer's test
Stier et al.	1936	A KINETIC ANALYSIS OF THE ENDOGENOUS RESPIRATION OF BAKERS'YEAST
Gourley et al.	1950	The effect of temperature upon the uptake of radioactive phosphate by human erythrocytes in vitro
Pauly et al.	1976	Whole blood microculture assay of human lymphocyte function
US3897363A (en)	1975-07-29	Blood control standard
Barakat et al.	1970	Biochemical analysis of normal camel blood
ES8105032A1 (es)	1981-04-01	Procedimiento para la produccion de oxidasa de alcohol
BAKER et al.	1966	A riboflavin assay suitable for clinical use and nutritional surveys
Mian et al.	1973	Studies on mitochondrial membrane proteins in Saccharomyces cerevisiae under different degrees of glucose repression
Keilin et al.	1947	Stability of haemoglobin and of certain endoerythrocytic enzymes in vitro
Kaufman et al.	1987	Evaluation of sulfhydryl oxidase as a strengthening agent for wheat flour dough
US3834991A (en)	1974-09-10	Colorimetric assay for lysozyme
Wolfson	1957	Location of alpha-2-globulin by demonstration of alkaline phosphatase during paper electrophoresis
FISHMAN et al.	1961	Enzymorphology: A study of free cells